Anthem Bioscienc

{
  "main_header": {
    "sid": 10039665,
    "name": "Anthem Bioscienc",
    "stock_name": "Anthem Bioscienc",
    "full_name": "Anthem Biosciences Ltd",
    "name_url": "stocks-analysis/anthem-bioscienc",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "645.90",
    "chg": 12.75,
    "chgp": "2.01%",
    "dir": 1,
    "prev_price": "633.15",
    "mcapval": "36,287.00 Cr",
    "mcap": "Mid Cap",
    "scripcode": 544449,
    "symbol": "ANTHEM",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE0CZ201020",
    "curr_date": "Mar 20",
    "curr_time": "",
    "bse_nse_vol": "1.87 lacs",
    "exc_status": "Active",
    "traded_date": "Mar 20, 2026",
    "traded_date_str": "2026 03 20",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/anthem-bioscienc-10039665-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Anthem Biosciences Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/anthem-biosciences-ltd-is-rated-sell-3905026",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/AnthemBioscienc_mojoScore_3905026.png",
        "date": "2026-03-21 10:10:03",
        "description": "Anthem Biosciences Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 09 Mar 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 21 March 2026, providing investors with the most up-to-date insight into the company’s performance and outlook."
      },
      {
        "title": "Anthem Biosciences Declines 3.20% Amid Mixed Technical Signals and Market Volatility",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/anthem-biosciences-declines-320-amid-mixed-technical-signals-and-market-volatility-3890471",
        "imagepath": "",
        "date": "2026-03-14 09:02:32",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>Mar 09:</strong> Intraday low hit amid price pressure (Rs.608.40)</p>\n                    <p><strong>Mar 09:</strong> Technical momentum shifts to sideways trend</p>\n                    <p><strong>Mar 10:</strong> Downgrade to Sell rating announced</p>\n                    <p><strong>Mar 11:</strong> Technical momentum shifts to mildly bearish despite intraday gain</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.661.05</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.639.90</div><div..."
      },
      {
        "title": "Anthem Biosciences Ltd Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/anthem-biosciences-ltd-technical-momentum-shifts-amid-mixed-market-signals-3884474",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/AnthemBioscienc_technicaldot_3884474.png",
        "date": "2026-03-11 08:04:16",
        "description": "Anthem Biosciences Ltd has experienced a notable shift in its technical momentum, moving from a sideways trend to a mildly bearish stance. Despite a modest day gain of 1.82%, the stock’s technical indicators present a complex picture, reflecting mixed signals across weekly and monthly timeframes. This analysis delves into the recent price action, key technical indicators such as MACD, RSI, moving averages, and broader market comparisons to provide investors with a comprehensive view of the stock’s current positioning."
      },
      {
        "title": "Anthem Biosciences Downgraded to Sell Amid Technical and Financial Weakness",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/anthem-biosciences-downgraded-to-sell-amid-technical-and-financial-weakness-3882208",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/AnthemBioscienc_mojoScore_3882208.png",
        "date": "2026-03-10 08:43:11",
        "description": "Anthem Biosciences Ltd has seen its investment rating downgraded from Hold to Sell as of 9 March 2026, reflecting a combination of deteriorating technical indicators, disappointing quarterly financial results, and valuation concerns. The company’s Mojo Score has declined to 40.0, signalling caution for investors amid sideways technical trends and weakening profitability metrics."
      },
      {
        "title": "Anthem Biosciences Ltd Hits Intraday Low Amid Price Pressure on 9 Mar 2026",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/anthem-biosciences-ltd-hits-intraday-low-amid-price-pressure-on-9-mar-2026-3879442",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/AnthemBioscienc_priceRelatedfactors_3879442.png",
        "date": "2026-03-09 09:32:25",
        "description": "Anthem Biosciences Ltd experienced a notable decline today, touching an intraday low of Rs 608.4, reflecting sustained price pressure amid broader market weakness and sector underperformance."
      },
      {
        "title": "Anthem Biosciences Ltd Technical Momentum Shifts Amid Market Volatility",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/anthem-biosciences-ltd-technical-momentum-shifts-amid-market-volatility-3879152",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/AnthemBioscienc_technicaldot_3879152.png",
        "date": "2026-03-09 08:02:17",
        "description": "Anthem Biosciences Ltd has experienced a notable shift in its technical momentum, transitioning from a mildly bullish stance to a sideways trend. Despite a recent downgrade in its Mojo Grade from Sell to Hold, the stock’s technical indicators reveal a complex picture of mixed signals, reflecting cautious investor sentiment amid volatile price action."
      },
      {
        "title": "Anthem Biosciences Declines 5.66% Amid Mixed Technical Signals and Sector Challenges",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/anthem-biosciences-declines-566-amid-mixed-technical-signals-and-sector-challenges-3877674",
        "imagepath": "",
        "date": "2026-03-07 09:02:18",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>2 Mar:</strong> Stock opens at ₹686.65, down 2.01% amid broad market weakness</p>\n                    <p><strong>4 Mar:</strong> Technical momentum shifts to sideways; stock closes at ₹666.70 (-2.91%)</p>\n                    <p><strong>5 Mar:</strong> Mojo Grade upgraded to Hold; technical momentum turns mildly bullish; stock closes at ₹666.35 (-0.05%)</p>\n                    <p><strong>6 Mar:</strong> Stock closes the week at ₹661.05, down 0.80%</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.700.70</div></div>\n                    <div class=\"stat-item\"..."
      },
      {
        "title": "Anthem Biosciences Ltd Upgraded to Hold on Technical and Financial Reassessment",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/anthem-biosciences-ltd-upgraded-to-hold-on-technical-and-financial-reassessment-3872906",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/AnthemBioscienc_mojoScore_3872906.png",
        "date": "2026-03-05 08:34:44",
        "description": "Anthem Biosciences Ltd has seen its investment rating upgraded from Sell to Hold as of 4 March 2026, reflecting a nuanced improvement across technical indicators, valuation metrics, financial trends, and overall quality. Despite recent quarterly setbacks, the company’s robust management efficiency and long-term growth prospects have contributed to this reassessment, signalling cautious optimism among investors."
      },
      {
        "title": "Anthem Biosciences Ltd Technical Momentum Shifts to Mildly Bullish Amid Mixed Returns",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/anthem-biosciences-ltd-technical-momentum-shifts-to-mildly-bullish-amid-mixed-returns-3872771",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/AnthemBioscienc_technicaldot_3872771.png",
        "date": "2026-03-05 08:05:26",
        "description": "Anthem Biosciences Ltd has experienced a notable shift in its technical momentum, moving from a sideways trend to a mildly bullish stance on the weekly charts. Despite a recent day decline of 3.58%, the stock’s technical indicators suggest a nuanced outlook, with mixed signals from MACD, RSI, and moving averages pointing to cautious optimism for investors in the Pharmaceuticals & Biotechnology sector."
      }
    ],
    "total": 16,
    "sid": "10039665",
    "stock_news_url": "https://www.marketsmojo.com/news/anthem-biosciences-10039665"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Cessation",
      "datetime": "13-Mar-2026",
      "details": "Anthem Biosciences Limited hereby informs the exchange of the resignation of Mr. K Ramakrishnan from the position of General Counsel and consequently from the role of Senior Management Personnel of the Company with effect from March 31 2026.",
      "source": "BSE"
    },
    {
      "caption": "Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 (SEBI LODR Regulations)",
      "datetime": "23-Feb-2026",
      "details": "Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulation 2025 we hereby inform that the Company has executed on February 23 2026 First amendment to the Loan agreement dated April 15 2024 entered with Neoanthem Lifesciences Private Limited (Wholly Owned Subsidiary).",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
      "datetime": "09-Feb-2026",
      "details": "Earnings Call Transcript for Q3 FY26",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Anthem Biosciences Ltd is Rated Sell

2026-03-21 10:10:03

Anthem Biosciences Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 09 Mar 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 21 March 2026, providing investors with the most up-to-date insight into the company’s performance and outlook.

Read full news article

Anthem Biosciences Declines 3.20% Amid Mixed Technical Signals and Market Volatility

2026-03-14 09:02:32

Key Events This Week

Mar 09: Intraday low hit amid price pressure (Rs.608.40)

Mar 09: Technical momentum shifts to sideways trend

Mar 10: Downgrade to Sell rating announced

Mar 11: Technical momentum shifts to mildly bearish despite intraday gain

Week Open

Rs.661.05

Week Close

Rs.639.90

Read full news article

Anthem Biosciences Ltd Technical Momentum Shifts Amid Mixed Market Signals

2026-03-11 08:04:16

Anthem Biosciences Ltd has experienced a notable shift in its technical momentum, moving from a sideways trend to a mildly bearish stance. Despite a modest day gain of 1.82%, the stock’s technical indicators present a complex picture, reflecting mixed signals across weekly and monthly timeframes. This analysis delves into the recent price action, key technical indicators such as MACD, RSI, moving averages, and broader market comparisons to provide investors with a comprehensive view of the stock’s current positioning.

Read full news article

Anthem Biosciences Downgraded to Sell Amid Technical and Financial Weakness

2026-03-10 08:43:11

Anthem Biosciences Ltd has seen its investment rating downgraded from Hold to Sell as of 9 March 2026, reflecting a combination of deteriorating technical indicators, disappointing quarterly financial results, and valuation concerns. The company’s Mojo Score has declined to 40.0, signalling caution for investors amid sideways technical trends and weakening profitability metrics.

Read full news article

Anthem Biosciences Ltd Hits Intraday Low Amid Price Pressure on 9 Mar 2026

2026-03-09 09:32:25

Anthem Biosciences Ltd experienced a notable decline today, touching an intraday low of Rs 608.4, reflecting sustained price pressure amid broader market weakness and sector underperformance.

Read full news article

Anthem Biosciences Ltd Technical Momentum Shifts Amid Market Volatility

2026-03-09 08:02:17

Anthem Biosciences Ltd has experienced a notable shift in its technical momentum, transitioning from a mildly bullish stance to a sideways trend. Despite a recent downgrade in its Mojo Grade from Sell to Hold, the stock’s technical indicators reveal a complex picture of mixed signals, reflecting cautious investor sentiment amid volatile price action.

Read full news article

Anthem Biosciences Declines 5.66% Amid Mixed Technical Signals and Sector Challenges

2026-03-07 09:02:18

Key Events This Week

2 Mar: Stock opens at ₹686.65, down 2.01% amid broad market weakness

4 Mar: Technical momentum shifts to sideways; stock closes at ₹666.70 (-2.91%)

5 Mar: Mojo Grade upgraded to Hold; technical momentum turns mildly bullish; stock closes at ₹666.35 (-0.05%)

6 Mar: Stock closes the week at ₹661.05, down 0.80%

Week Open

Rs.700.70

Read full news article

Anthem Biosciences Ltd Upgraded to Hold on Technical and Financial Reassessment

2026-03-05 08:34:44

Anthem Biosciences Ltd has seen its investment rating upgraded from Sell to Hold as of 4 March 2026, reflecting a nuanced improvement across technical indicators, valuation metrics, financial trends, and overall quality. Despite recent quarterly setbacks, the company’s robust management efficiency and long-term growth prospects have contributed to this reassessment, signalling cautious optimism among investors.

Read full news article

Anthem Biosciences Ltd Technical Momentum Shifts to Mildly Bullish Amid Mixed Returns

2026-03-05 08:05:26

Anthem Biosciences Ltd has experienced a notable shift in its technical momentum, moving from a sideways trend to a mildly bullish stance on the weekly charts. Despite a recent day decline of 3.58%, the stock’s technical indicators suggest a nuanced outlook, with mixed signals from MACD, RSI, and moving averages pointing to cautious optimism for investors in the Pharmaceuticals & Biotechnology sector.

Read full news article

View All News